argenx SE (STU:1AE)
€ 553.6 6 (1.1%) Market Cap: 33.43 Bil Enterprise Value: 30.56 Bil PE Ratio: 0 PB Ratio: 8.44 GF Score: 82/100

argenx SE Presents At Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 13, 2021 / 12:00PM GMT
Release Date Price: €216.8 (+2.46%)
Tazeen Ahmad
BofA Securities, Research Division - VP

Good morning, everybody. Welcome to the third day of the Bank of America Healthcare Conference. Presenting as our next company this morning is argenx. It's always a pleasure to have argenx team members with us. Leading today is going to be Tim Van Hauwermeiren, who we speak to very, very frequently; as well as Keith Woods. Keith and Tim, good morning or good afternoon, depending on where you are.

R. Keith Woods
argenx SE - COO

Good morning, Tazeen.

Timothy Van Hauwermeiren
argenx SE - CEO & Executive Director

Good morning. It's good to see you.

Tazeen Ahmad;Timothy Van Hauwermeiren
BofA Securities, Research Division - VP;argenx SE - CEO & Executive

So maybe we can take a second or 2 to just review where everything that's happened with argenx over the last year, and it's been many things. And from there, we can go into a little bit more detail on questions, if that works.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot